Standout Papers

Bevacizumab Plus Interfer... 2008 2026 2014 2020 2008 200 400 600

Immediate Impact

3 from Science/Nature 70 hit
Sub-graph 1 of 21

Citing Papers

Renal cell carcinoma
2024 Hit
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Hit
8 intermediate papers

Works of San-San Ou being referenced

Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206
2008 Hit
Predictors of Prostate Cancer Tissue Acquisition by an Undirected Core Bone Marrow Biopsy in Metastatic Castration-Resistant Prostate Cancer—A Cancer and Leukemia Group B Study
2005

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
San-San Ou 674 527 387 257 105 11 970
James L. Freddo 568 0.8× 563 1.1× 294 0.8× 396 1.5× 50 0.5× 27 1.2k
Perry Watts 241 0.4× 306 0.6× 212 0.5× 490 1.9× 21 0.2× 18 1.0k
Norihiro Yamaguchi 540 0.8× 469 0.9× 235 0.6× 498 1.9× 93 0.9× 23 1.1k
Arduino Verdecchia 234 0.3× 182 0.3× 187 0.5× 637 2.5× 43 0.4× 17 1.2k
Hans Messersmith 219 0.3× 271 0.5× 302 0.8× 549 2.1× 12 0.1× 26 1.2k
Karen Sanders 564 0.8× 82 0.2× 131 0.3× 249 1.0× 214 2.0× 16 1.2k
John D. Sprandio 250 0.4× 262 0.5× 235 0.6× 371 1.4× 11 0.1× 27 987
M. W. Dercksen 129 0.2× 113 0.2× 132 0.3× 275 1.1× 209 2.0× 20 968
N. E. Day 176 0.3× 37 0.1× 205 0.5× 402 1.6× 54 0.5× 19 851
Hyuk‐Chan Kwon 571 0.8× 190 0.4× 48 0.1× 657 2.6× 53 0.5× 17 1.2k

All Works

Loading papers...

Rankless by CCL
2026